Waters (NYSE:WAT) executives said the company closed out 2025 with a “strong finish” and entered 2026 with a major portfolio ...

Waters Corporation (NYSE:WAT) reported consistent progress across its core product portfolio, supported by ongoing instrument ...

Waters Advanced Diagnostics (formerly BD Diagnostic Solutions and Waters Clinical Business): comprised of products and service for high-value diagnostic workflows in regulated clinical settings. This ...

Q4 2025 Earnings Call February 9, 2026 8:30 AM ESTCompany ParticipantsCaspar Tudor - Head of Investor RelationsUdit Batra ...

Synfini, Inc ., provider of the industry's most advanced Agile AI Foundry for drug discovery, today announced the integration of microscale purification into high throughput experimentation (HTE) ...

Announces appointment of Claire M. Fraser, Ph.D., to its Board of DirectorsForms a global life sciences and diagnostics leader focused on high-volume testing in regulated applicationsAnnounces ...

Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $2.91 in the first ...

Sample filtration prior to HPLC, UHPLC, LC/MS, GC, or GC/MS analysis is critical to achieving optimal system performance. Agilent Captiva Premium Syringe Filters make the process faster than ever with ...

LCGC International salutes Jack Henion and Bob W.J. Pirok, winners of the 19th annual LCGC Lifetime Achievement and Emerging ...

The surge is fueled by technological advancements and growing demand for high-precision data across healthcare, ...

Revenue of $5.3 billion increased 1.6% as reported, 0.4% FXN New BD revenue increased 2.5% FXN GAAP and adjusted diluted EPS of $1.34 and $2.91, respectively Combination ...

The conversion of large-scale, complex mass spectrometry data into meaningful structural insights through ChemEcho, a machine learning embedding method, published in August by investigators at ...